These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 9432808)

  • 21. The quest for the perfect biomarker of long-term glycemia: new studies, new trials and tribulations.
    Foo JP; Mantzoros CS
    Metabolism; 2011 Dec; 60(12):1651-4. PubMed ID: 21820137
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of two point-of-care analysers for measurement of fructosamine or haemoglobin A1c in dogs.
    Davison LJ; Podd SL; Ristic JM; Herrtage ME; Parnham A; Catchpole B
    J Small Anim Pract; 2002 Dec; 43(12):526-32. PubMed ID: 12489740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus.
    Polgreen PM; Putz D; Stapleton JT
    Clin Infect Dis; 2003 Aug; 37(4):e53-6. PubMed ID: 12905153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
    Gołembiewska E
    Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fructosamine as a parameter for monitoring carbohydrate metabolism in the treatment of diabetes mellitus].
    Rotmann D; Husemann C; Schönherr U; Mitzkat HJ
    Wien Klin Wochenschr Suppl; 1990; 180():69-71; discussion 78-81. PubMed ID: 2321397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The usefulness of fructosamine determination in diabetic patients and its relation to metabolic control.
    Daubresse JC; Laurent E; Ligny C; Bailly A; Lemy C; Duchateau A; Meunier JC
    Diabete Metab; 1987 Jun; 13(3):217-21. PubMed ID: 3609423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical validity of a self-test fructosamine in outpatient diabetic management.
    Cefalu WT; Wang ZQ; Redmon E; Bell-Farrow AD; McBride D; King T
    Diabetes Technol Ther; 1999; 1(4):435-41. PubMed ID: 11474829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.
    Danese E; Montagnana M; Nouvenne A; Lippi G
    J Diabetes Sci Technol; 2015 Mar; 9(2):169-76. PubMed ID: 25591856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study.
    George C; Matsha TE; Korf M; Zemlin AE; Erasmus RT; Kengne AP
    BMC Nephrol; 2020 Jan; 21(1):32. PubMed ID: 32000712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new fructosamine test--as a routine parameter in the control of diabetes].
    Willms B; Lehmann P
    Wien Klin Wochenschr Suppl; 1990; 180():5-10. PubMed ID: 2181784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
    Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
    Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure.
    Morgan L; Marenah CB; Jeffcoate WJ; Morgan AG
    Diabet Med; 1996 Jun; 13(6):514-9. PubMed ID: 8799653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Albumin or protein standardized fructosamine-plus, 2 new indices for evaluating diabetic metabolic status].
    Furrer J
    Wien Klin Wochenschr Suppl; 1990; 180():85-93; discussion 95-7. PubMed ID: 2321401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing glycaemic control in diabetes: relationships between fructosamine and HbA1C.
    Braatvedt GD; Drury PL; Cundy T
    N Z Med J; 1997 Dec; 110(1057):459-62. PubMed ID: 9451409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between glycated haemoglobin and glucose testing for diabetes mellitus screening.
    Agarwal N; Joshi S; Deshpande VK; Biswas DA
    Indian J Med Sci; 2013; 67(7-8):149-54. PubMed ID: 24469558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assay for serum fructosamine in diabetes].
    Piaserico G; Piaserico P
    Quad Sclavo Diagn; 1986 Sep; 22(3):303-11. PubMed ID: 3615802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients.
    Mittman N; Desiraju B; Fazil I; Kapupara H; Chattopadhyay J; Jani CM; Avram MM
    Kidney Int Suppl; 2010 Aug; (117):S41-5. PubMed ID: 20671744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum fructosamine determination as an index of glycaemic control: comparison between an automated and manual method, and the effect of serum storage.
    Ng WY; Thai AC; Lui KF; Koay ES
    Ann Acad Med Singap; 1989 Jul; 18(4):352-6. PubMed ID: 2802502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum fructosamine: a parameter for monitoring metabolic control in diabetes.
    Gomo Z
    Cent Afr J Med; 1992 Sep; 38(9):358-62. PubMed ID: 1298563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.